CD-CODE 2.0:一个增强的凝结物知识库,整合了病理生物学,凝结物调节药物和宿主-病原体相互作用.
Ksenia Kuznetsova1,2, Maxim Scheremetjew1,2, Jialin Yin1,2
1Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.
Nucleic acids research
|November 9, 2025
概括
CD-CODE 2.0 是一个升级的数据库,用于研究生物凝结物. 它现在包括新的数据类型和改进的搜索功能,以推进凝结物生物学研究和药物发现.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 系统生物学 系统生物学
背景情况:
- 生物凝结物对于细胞的组织和功能至关重要.
- 了解凝结物生物学是解决各种疾病的关键.
- 以前的CD-CODE版本提供了对冷凝液的基本数据.
研究的目的:
- 推出CD-CODE 2.0,一个增强的Web应用程序和数据库,用于凝结物研究.
- 扩大凝结物数据的范围,包括核酸,传染病原体,药物和疾病联系.
- 改进数据的可访问性,并使系统层面的分析能够产生假设和治疗发现.
主要方法:
- 开发一个增强的网络应用程序和数据库 (CD-CODE 2.0).
- 整合新的数据类别:核酸成分,传染性缩物,调制药物和与疾病相关的缩物.
- 实施增强的搜索功能,编程访问和关系架构.
主要成果:
- CD-CODE 2.0提供了有关凝结物生物学各个方面的扩展数据.
- 该应用程序提供了增强的搜索和程序访问与冷凝相关的信息.
- 关系架构促进了与其他主要生物医学数据库的互连.
结论:
- CD-CODE 2.0显著提高了生物医学研究的凝聚数据的实用性.
- 该平台支持系统层面的洞察力,加速假设生成.
- 这个资源准备好在凝结物生物学中推进治疗发现.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
257
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
257
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
202
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
202
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Microorganisms in Medicine and Therapeutics
922
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Nursing Clinical Information System
1.2K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.2K


